Tengion Overview

Founded 2003
Status Public
Employees 11
Stock Symbol TNGNQ
Stock Symbol

Tengion General Information


Tengion Inc is a regenerative medicine company. The company is engaged in discovering, manufacturing and commercializing neo-organs, or products composed of living cells, with or without synthetic or natural materials, implanted or injected into the body to engraft into, regenerate, or replace damaged tissue or organ. Its product candidates seek to eliminate the need to utilize other tissues of the body for a purpose to which they are poorly suited, procure donor organs or administer anti-rejection medications. The company's solution Neo-Kidney Augment is based on its proprietary technology, which uses tubular epithelial cells, procured by a cortical biopsy of the patient's kidney, to create an injectable product candidate that can catalyze the regeneration of functional kidney tissue.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Other Industries
Drug Discovery
Stock Exchange
Primary Office
  • 3929 Westpoint Boulevard
  • Suite G
  • Winston-Salem, NC 27103
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Tengion Stock Performance

(As of Tuesday closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS

Tengion Financials Summary

In Thousands,
TTM 30-Sep-2014 FY 2013 31-Dec-2013 FY 2012 31-Dec-2012 FY 2011 31-Dec-2011
EV 21,804 2,588 6,175 (2,938)
Revenue 0 0 0 0
EBITDA (56,419) (11,085) (13,543) (15,124)
Net Income (64,426) (18,927) (16,929) (19,061)
Total Assets 9,621 25,724 12,435 17,817
Total Debt 34,122 26,952 11,269 4,987
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Tengion Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Tengion‘s full profile, request access.

Request a free trial

Tengion Competitors (24)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
ViaCyte Venture Capital-Backed San Diego, CA 00 00000 00000000000 00000
000 0000000000000 Venture Capital-Backed Seattle, WA 00 000.00 0000000000 0 000.00
00000000 Venture Capital-Backed South San Francisco, CA 0000 00000000000 0000
00000 0000000000 Accelerator/Incubator Backed Phoenix, AZ 0000 000000000000 0000
000000 0000000 Accelerator/Incubator Backed Marietta, GA 000000000000

Tengion Executive Team (12)

Name Title Board Seat Contact Info
A. Davis MD Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
John Miclot Chief Executive Officer & Board Member
Timothy Bertram Ph.D Chief Scientific Officer & President

9 Former Executives

Tengion Board Members (11)

To view Tengion‘s full board member team, request access >>
Name Representing Role Since
0000-00000 000000000 00.0 Self Board Member 000 0000
00000 000000 Tengion Chairman & Board Member 000 0000
00000 00000000 00 Self Board Member 000 0000
0000 000000 Self Chief Executive Officer & Board Member 000 0000
0000000 00000 00 Self Board Member 000 0000

6 Former Board Members

Ready to get started?

Request a free trial